TABLE 1.
Socio‐demographic, clinical characteristics, and treatment regimens of gastrointestinal cancer patients.
| Esophageal cancer (n = 160) | Gastric cancer (n = 103) | Colorectal cancer (n = 96) | ||
|---|---|---|---|---|
| Variable | Frequency, N (%) | Frequency, N (%) | Frequency, N (%) | p‐value |
| Age (in years) | <.001* | |||
| <60 years | 71 (44.4) | 47 (45.6) | 66 (68.8) | |
| ≥60 years | 89 (55.6) | 56 (54.4) | 30 (31.2) | |
| Gender | .819 | |||
| Male | 97 (60.6) | 64 (62.1) | 62 (64.6) | |
| Female | 63 (39.4) | 39 (37.9) | 34 (35.4) | |
| Histological type | <.001* | |||
| Adenocarcinoma | 15 (9.4) | 101 (98.1) | 95 (99) | |
| Squamous cell carcinoma | 145 (90.6) | 2 (1.9) | 1 (1) | |
| Stage of cancer | <.001* | |||
| Stage I | 11 (6.9) | 1 (1.0) | 3 (3.1) | |
| Stage II | 55 (34.4) | 21 (20.4) | 11 (11.5) | |
| Stage III | 53 (33.1) | 46 (44.7) | 32 (33.3) | |
| Stage IV | 41 (25.6) | 35 (33.9) | 50 (52.1) | |
| Comorbidity | .014* | |||
| Present | 89 (55.6) | 65 (63.1) | 41 (42.7) | |
| Absent | 71 (44.4) | 38 (36.9) | 55 (57.3) | |
| Treatment regimen | <.001* | |||
| Surgery | 49 (30.6) | 23 (22.3) | 12 (12.5) | |
| Chemotherapy and radiotherapy | 32 (20) | 6 (5.8) | 16 (16.7) | |
| Chemotherapy | 6 (3.8) | 36 (35) | 21 (21.9) | |
| Radiotherapy | 17 (10.6) | 1 (1) | 1 (1) | |
| Surgery and chemotherapy | 4 (2.5) | 13 (12.6) | 25 (26) | |
| Symptomatic management | 30 (18.8) | 20 (19.4) | 6 (6.3) | |
| Radiotherapy, chemotherapy and surgery | 11 (6.9) | 4 (3.9) | 15 (15.6) | |
| Radiotherapy and surgery | 11 (6.9) | 0 (0) | 0 (0) |
*
Statistically significant at p < .05.